basic fluid therapy-merc, des-2012

Upload: eka-rianti

Post on 07-Jul-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    1/52

    Basic Fluid Therapy

    Hasanul Arifn

    DEPARTEMEN ANESTESIOLOGI DAN TERAPI INTENSIFFaul!as "ed#!eran $S$ MEDAN

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    2/52

      FLUID MANAGEMENT

      INTRAVASCULAR VOLUME

      HEMODYNAMIC MECHANISM

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    3/52

    4/12/16 3

    PRE-LOAD CONTRACTILITY AFTER-LOAD

    STROKE VOLUME HEART-RATE

    CARDIAC OUTPUT SYSTEMIC

    VASCULAR

    RESISTANCE

    BLOOD

    PRESSUREHasanul, 2006

    Tissue

    Perfusion

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    4/52

    pere!"e# $er%!&!p

    H'O ( p!r$i)#e *e)i#

    Permeabel terhadapH2O saja

    ICF

    ISF

     VF

    E%F

    I%F

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    5/52

     TOTAL BODY WATER : 60% TOTAL BODY WEIGHT

    +, L

    ISF

    , *.

    /L

    ISF IVF ICF

    +L '0 L

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002pere!"e# $er%!&!p H'O (p!r$i)#e *e)i#

    Permeabel terhadapH2O saja

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    6/52

    "ris!al#id

      Kristaloid adalah terminology yangdigunakan untuk cairan yang tidak

    mengandung molekul molekul besar,sehingga tidak memiliki kekuatan(tekanan) onkotik ( tekanan onkotik = 0)

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    7/52

    "#l#id  Kolloid adalah terminology yang

    digunakan untuk cairan yangmengandung molekul molekul besar

    (≥ 30.000) sehingga memiliki tekananonkotik  menaga air teta! dalamkom!artemen intra"askular.

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    8/52

    Teanan On#!i 

       #ekanan onkotik adalah kekuatan untuk

    menahan air (H2$) tidak keluar darikom!artemen intra"askular,

    to hold %ater

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    9/52

    "#l#idA#"uin2 HES2

    E3p!fusin2

    4e#!$ine2 #

    "ris!al#id 

    D562 RL2 RA2

    N!C# 7/8

    %airan

    Nu!risi In$r!fusin2 I9e#ip2

    Triofusin 2 #

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    10/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L'5 #

    D5W= H&O

    :5#

    Physiologic principlesof fluid management

    3L

    ' L

    Not forresuscitation !!!

    EDEMA

    hyp#!#nic

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    11/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L:5 #

    CRYSTALLO D

    RL, RA,

    NaCl 0.9%

    ''5#

    Physiologic principlesof fluid management

    edema intersitiel

    3L

    Membutuhkan volume yang

    lebih besar,Lebih murah,

    Side effek lebih kecil

    Is#!#nic 'uid

    &dema !eri'er !ada !asien trauma atau !ost o!erati!, tidak meru!akan tanda adekuatnya "olume

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    12/52

    al(u)in

      Bila albumin berkurang s/d !"# $OP akan menuruns/d 1/3 dari nilai n%rmal

      Plasma hal& li&e 16 jam

      'alam 2 jam p%st in&usi# 1 gr albumin akan

    menge(pansi intra)askular 2! (  $%nt%h *

    1!!! ml albumin " +! gr albumin, akan mengekpansi

    intra)askular )%lume sebesar !(2! - 1!!! ml

    1!! ml albumin 2" +2 gr albumin, akan mengekpansiintra)askular )%lume sebesar 2(2! - !! ml

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    13/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L;L

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002

     Albumin-5%1 Lexpensiveexpensive

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    14/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L5 #

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002

    0

     Albumin-25%100 mlexpensiveexpensive

    VOLUME

    E

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    15/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L;L

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002

    HES-6%, 200/0.51 L

    •Lebih cepat mengkoreksi volume intra vaskular

    • Mempertahankan tekananonkotik intravaskular

    • Lebih mahal dari kristalloid

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    16/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L: #

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002

    •Lebih cepat mengkoreksi volume intra vaskular

    • Mempertahankan tekananonkotik intravaskular

    • Lebih mahal dari kristalloid

    •  sebagian shift ke ISC

    +

    POLYGELINE(HAEMACCEL)

    1 Liter

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    17/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L;

    #

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2002

    •Lebih cepat mengkoreksi volume intra vaskular

    • Mempertahankan tekananonkotik intravaskular

    • Lebih mahal dari kristalloid

    GELATIN(GELOFUSINE)

    1 Liter

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    18/52

    ISF

    /L

    ISF IVF ICF

    +L '0 L;,

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2009

    ',

    Dextran – 401 L

    +0

    •Lebih cepat mengkoreksi volume intra vaskular

    • Mempertahankan tekananonkotik intravaskular

    •  volume expand

    • Coagulopathy

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    19/52

    ISFISF IVF ICF

    +L '0 L

    P%1sio#o.i) prin)ip#es

    of f#ui& !n!.een$

    Hasanul, 2010

    /L

    7.5%-Hypertonic Saline

    ?ml

    . Subjek untuk penelitian

    . Resusitasi cepat, volumesedikit

    . Mengurangi cerebraledema

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    20/52

      Hy!ertonic saline

      Hpert%ni0 s%luti%ns and hpert%ni0/hper%n0%ti0

    s%luti%ns ma impr%)e 0ardi%)as0ular &un0ti%n %n

    multiple le)els*displa0ement %& tissue &luid int% the bl%%d 0%mpartment

    dire0t )as%dilat%r e&&e0ts in the sstemi0 and pulm%nar0ir0ulati%n#

    redu0ti%n in )en%us 0apa0itan0e#

    p%siti)e in%tr%pi0 e&&e0ts thr%ugh dire0t a0ti%ns %n

    m%0ardial 0ells

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    21/52

     alin hi!ertonika!abila diin'uskan akan memindahkan cairan dari

    intraselular ke ekstraselular ( interstitial danintra"askular dengan !erbandingan seuai dengan

    !erbandingan "olume kom!artemen)

    %lume g akan pindah-

    + kadar a$l hipert%nik * !, ( )%lume a$l

    hipert%nik ang diin&uskan

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    22/52

    20 m* +al -.

      %lume g akan pindah

    - +5 * !, ( 2! m - 2!73 m

      %lume ekstrasellular akan bertambah

    sebesar * 2! 8 2!73 - 2333 m

      dari jumlah ini akan didistribusikan sbb *73 m IF dan 1!! m ISF

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    23/52

      /enecial e1ects o' hy!ertonicsaline solutions %ere re!orted to berather transient.

      onseuently, hy!ertonic solutions%ere o'ten mied %ith colloids(detran or H&), and these

    solutions sho%ed a !rolongede4cacy.

      Hy!ertonic saline

    R/ H5

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    24/52

    7

    menurun

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    25/52

    9ed Bl%%d $ell

    High :; parti0les

    + :; parti0le

    +a8# $l # glu0%se,

    PERIPHERAL %APILLARIES

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    26/52

    9ed Bl%%d $ell

    High :; parti0les

    + :; parti0le

    +a8# $l # glu0%se,

    CEREBRAL CAPILLARIES

    BBB

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    27/52

    Fluid Movement BetweenCapillaries and the Brain

    In the presence of an intact BBB

      Perpindahan cairan antara capiler dan

    extracellular space otak terutama olehgradient osmotik(osmolarity).

      Pada jaringan otak, ( tidak seperti pada jaringan di peripheral ), plasma oncotic

     pressure kecil perannya dalam prosesperpindahan cairan.

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    28/52

    Clinical implication

      Hyperglycemia  harus dihindarkan padapasien yang mengalami brain ischemia .

     

    Larutan Dextrose jangan diinfuskan padapasien yang akan menjalani prosedur bedahsyaraf, kecuali dibutuhkan untuk terapi atau

    pencegahan hypoglikemia..

    $h%pp et al# +177, Str%ke# 1

    anier et al# +175, and :etab%lism# 6

    atale et al +1!, 9esus0itati%n# 1

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    29/52

    Intraoperative Fluids,Crystalloids

      =@ui+is%,%sm%lar t% n%rmal plasma +2!A2 mOsm/,

       F l u i d Osmolarity(mOsm/L)

    Lactated Ringer’s Solution Acetate Ringer’s Solution

    Ringer’s Solution

    0.9% Saline

    0.45% Saline20% Mannitol

    273273

    310

    308

    1541098

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    30/52

    %R*STALLOID 

    3!

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    31/52

      om!osition resembling !lasma(acetated ringer, lactated ringer)

      8ree o' ana!hylactic reaction

      7e!laces 98

      7a!id in'usion

      &asily a"ailable

      *o%er cost, chea!  :reater urinary ;o%

      &asy storage at room tem!erature

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    32/52

    d isad "an tages

    32

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    33/52

    33

    ISF

    ISFIVF ICF

    :5 #

    %R*STALLOID

    RL+ RA+ Na%l ,-./

    ''5#

    3L

    $%nse@uentl large @uantities %& &luid +at least 3 t% 4 times

    the a0tual intra)as0ular )%lume de&i0it, ha)e t% be in&used

    t% a0hie)e n%rm%)%lemia >hen 0rstall%id &luid regimen is

    0h%sen?%a0him B%ldt# :'# Ph'# In$r!oper!$i9e f#ui& $%er!p1-)r1s$!##oi&=)o##oi& &e"!$eCONFERENCIAS MA4ISTRALES %l 27 Supl 1 2!! pp S23AS27

    se"ere dilution o' !lasma !roteinconcentration is accom!anied by

    a (critical) reduction

    in !lasma $ %ith the risk o'increasing interstitial edema and

    com!romise organ !er'usion

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    34/52

    ISF ISFIVF ICF

    +L '0 L/L

    7.5%-Hypertonic Saline

    ?ml

    . Subjek untuk penelitian

    . Resusitasi cepat, volume

    sedikit. Mengurangi cerebraledema

    %lume g akan pindah - + kadar a$l hpert%nik *

    ! , ( )%lume a$l hpert%nik ang diberikan

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    35/52

      /enecial e1ects o' hy!ertonicsaline solutions %ere re!orted to berather transient.

      onseuently, hy!ertonic solutions%ere o'ten mied %ith colloids(detran or H&), and these

    solutions sho%ed a !rolongede4cacy.

      Hy!ertonic saline

    R/ H5

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    36/52

      Hy!ertonic saline

      Hpert%ni0 s%luti%ns and hpert%ni0/hper%n0%ti0

    s%luti%ns ma impr%)e 0ardi%)as0ular &un0ti%n %n

    multiple le)els*displa0ement %& tissue &luid int% the bl%%d 0%mpartment

    dire0t )as%dilat%r e&&e0ts in the sstemi0 and pulm%nar

    0ir0ulati%n#

    redu0ti%n in )en%us 0apa0itan0e#

    p%siti)e in%tr%pi0 e&&e0ts thr%ugh dire0t a0ti%ns %n

    m%0ardial 0ells

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    37/52

      *7 ( racemic * > 5 isomer) a!!ears toha"e a !roin;ammatory e1ect, but thismay be ameliorated by modication o'its com!osition.

       7inger olution, 7inger S SOLUTION IN HAEMORRHA4IC SHOCK2

    NO6 AND THE FUTURE

    MA K%!n;2 ?P 4!rner'

    35

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    38/52

    ?icrocirculation,tissue $2

      < massi"e crystalloid resuscitation alone is less likely toachie"e adeuate restoration o' blood ;o% and tissue $2 (Funk# et al# 1)

      *actated 7inger@s solution did not restoremicro"ascular !er'usion su4ciently. (Aang et al , BCC0)

      olloids are able to restore microcirculatory !er'usion

    more than crystalloids (*ang.K, 200B)

    37

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    39/52

      haracteristic o' the substance oncentration ()

    ?olecular Aeight ( D0, 200,B30,-0)

    5egree o' subtitution (0.- E 0.E 0.D) attern o' substitution (2F6)

    H &  

    6"H& 13!/!42   

    3

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    40/52

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    41/52

    ?olecular Aeight

      In$r!9!s)u#!r persis$en)e

      Tissue s$or!.e

    ?olecular Aeight 

    41

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    42/52

    42

    Haemostasis and Coagulation

      9edu0ti%n %& &a0t%r III and )%n ;illebrandCs

    &a0t%r a0ti)it  Impairment %& platelet &un0ti%n

      In0reases in the

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    43/52

    43

    Interference with haemostasis and

    coagulation depend on : M, degree!molar" of substitution and #$%#& ratio

    MW, degree (molar) ofsubstitution and C2/C6

    ratio

    effect

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    44/52

     44

    '() *+D (+*L -+#/I0+

      Hyperoncotic Renal Failure

    (Moran and Kapsner)

      Generation of a high plasma COP wichcounteracts the hydrostatic pressure

    gradient in the glomerulus

    Avoidance of hyperoncotic colloid

    solutions

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    45/52

    4

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    46/52

    46

    HES 130/0./11.!H & (B30F0.DFC) 

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    47/52

    0GELATIN1

    45

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    48/52

    2ela!in  $ksi!oligelatin  oligelin

     

    Gela!in p#lisusina!

    uksinilasi menghasilkan !elebaran strukturmolekul, yang !ada akhirnya akan

    meningkatkan e'ek "olumedibandingkan dengan gelatin tan!asuksinilasi.

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    49/52

    4

    ISFISF IVF ICF

    :-

    #

    Hasanul# 2!!2

    • More rapidly correcthypovolemia

    Maintain intravascularoncotic pressure

    • anaphylactoid

    •  shift to ISF

    2!!A3!!

    ml

    4e#!$in; L

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    50/52

    Thank you for

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    51/52

    7e!lace acuteF

  • 8/18/2019 Basic Fluid Therapy-MERC, DeS-2012

    52/52

    increases 98 &8increases 98 &8

    I%F ISF Plas)a

    7e!lace +ormalloss (9A* I urine)

    7e!lace +ormalloss (9A* I urine)

      detroseF ?aintenance sol detroseF ?aintenance sol

    54 )l&44 )l66, )l

    B * o'

    H1po$oni) infusion